ABSTRACT
INTRODUCTION
Recently, it has been reported that bone marrow cells (BMCs) differentiate into various cells, including hepatocytes [1] , endothelial cells of the blood vessel [2] , epithelial cells of the stomach, esophagus, small intestine, large intestine and bronchus [3] , cardiac muscle [4] , and skeletal muscle [5] . It has also been reported that BMCs differentiate into neural cells and astrocytes in vitro [6, 7] and also into astrocytes in vivo when transplanted into the normal [8, 9] or ischemic brain [10] . Moreover, the intravenous injection of BMCs into mice has been shown to induce neuronal differentiation in the brain [11] [12] [13] ; BMCs have the capacity to differentiate into myelin-forming cells in vivo and to repair demyelinated spinal cord axons [14] . These findings suggest that BMCs can differentiate into nerve cells under the appropriate conditions. On the other hand, neural stem cells can generate hematopoietic cells in vivo, indicating that neural precursor cells are not restricted to the differentiation of neural-lineage cells [15] . There are many studies of retinal transplantation using the newborn or the embryonic Stem Cells ® Original Article brain [16, 17] and retina-derived neural cells [18] [19] [20] [21] . Moreover, hippocampus-derived neural stem cells have been shown to differentiate into neural-forming cells, which are then incorporated into the injured retina [22] [23] [24] [25] . However, it is still unclear whether BMCs can differentiate into nerve cells in the retina. The present study demonstrates that BMCs can differentiate into retinal neural cells (cells of the outer nuclear layer [ONL]) in vivo, and that the cells express glial fibrillary acidic protein (GFAP), calbindin, rhodopsin, and vimentin.
MATERIALS AND METHODS

Preparation of Stem Cell-Enriched BMCs for Grafting
We prepared partially purified stem cell-enriched BMCs as previously described [26] [27] [28] . Briefly, 5-fluorouracil (Kyowa Hakko Kogyo; Tokyo, Japan) was injected into the peritoneal cavity of 4-week-old male Brown Norway rats (Clea Japan; Osaka, Japan) at 150 mg/kg body weight 48 hours before sacrifice. The BMCs were obtained from femurs and tibias, and were fractionated by density centrifugation using Lymphoprep ™ density solution (density, 1.077; Nycomed Pharma; Oslo, Norway; http://www. nycomed.com). After centrifugation, whole mononuclear cells, as stem cell-enriched BMCs, were collected from the interface and were labeled using PKH67 (green fluorescence; MINI-67; Sigma; Saint Louis, MO; http://www.sig maaldrich.com).
Rats and Grafting Procedure
Rats (15-to 18-week-old Brown Norway rats; n = 6) were anesthetized with pentobarbital sodium (10 mg/kg body weight; Somnopentyl; Pitman-Moore; Washington Crossing, NJ), which was injected into the abdominal cavity. The pupils were dilated with 0.5% tropic amide (Santen; Osaka, Japan; http://www.santeninc.com). The corneas were further anesthetized with drops of 0.4% oxybuprocaine hydrochloride (Santen). The eyeballs were perforated at the equator with a 30-gauge needle, and the retina was injured by scratching parallel to the equator between the retinal vessels under direct observation with a surgical microscope equipped with a plano-concave contact lens for rats (Kyocon; Kyoto, Japan). Special care was taken to injure the whole layer of the retina. After the injury, 20 µl of the cell suspension, containing 200,000 cells, were slowly injected into the intravitreous space with the injector (six rats, six eyes). As a control, 20 µl of normal saline solution were injected into the intravitreal space of the injured eyes (six rats, six eyes). The results from one eye of the control group were excluded due to complication of massive vitreous hemorrhage.
Tissue Sectioning
The animals were sacrificed 2 weeks after injection. The eyes were enucleated and embedded in optimal cutting temperature compound (Miles; Elkhart, IN) after adjustment of their horizontal planes parallel to the cutting plane, and 2 µm frozen sections were made in a cryostat. Continuous sections including the injury site were cut for each eye.
Antibodies
Antibodies (Abs) used in this study were as follows: rabbit polyclonal anti-GFAP; 1:1,000; Sigma), rabbit antirhodopsin (1:500; LSL; Tokyo, Japan), mouse monoclonal anticalbindin-D28K (1:1,000; Sigma), monoclonal mouse antivimentin (1:100; Dako; Glostrup, Denmark; http://www.dako.dk), anti-rat CD45 (1:50; PharMingen; San Diego, CA; http://www.bdbiosciences.com/pharmin gen), R-phycoerythrin (PE)-conjugated goat anti-mouse Ab (1:50; PharMingen), and R-PE-conjugated goat anti-rabbit Ab (1:500; Southern Biotechnology Associates; Birmingham, AL; http://www.southernbiotech.com).
Immunocytochemistry
The specimens, which had been fixed with acetone, were stained with rabbit Abs (anti-GFAP or antirhodopsin) or mouse Abs (anticalbindin and antivimentin) followed by staining with PE-labeled goat anti-rabbit Ab or PE-labeled goat anti-mouse Ab. For staining with anti-CD45, the specimens were stained with PE-labeled anti-CD45 Ab. The stained specimens were observed using a confocal microscope (Fluoview; Olympus; Tokyo, Japan; http://www.olympus.com).
RESULTS
Incorporation and Distribution of Injected Cells
Since it has been reported that BMCs have the ability to differentiate into various lineage cells, we examined whether they can differentiate into retinal cells. Previously, Nishida et al. reported that hippocampus-derived neural stem cells could not migrate into the intact retina, whereas they could do so into the injured retina [22] . Therefore, we injected BMCs into the vitreous space after injuring the retina. At first, we injected whole BMCs into the vitreous space after injuring the retina, but this maneuver induced severe inflammation in the eye. Therefore, we enriched bone marrow stem cells, as described above, and injected these into the vitreous space after injuring the retina. Two weeks after transplantation, we killed the injected rats and examined their eyes. The injected stem cell-enriched BMCs had been incorporated into the host retina in 83% of the experimental eyes (5/6). Injured retina, after injection of Tomita, Adachi, Yamada et al. 281 saline, showed rolling in the retina (Fig. 1A) , while injured retina, after injection of stem cell-enriched BMCs, showed cell proliferation in the ONL (Fig. 1B) . These findings suggest that mechanical injury induces only disorders of the retina, but the injection of stem cell-enriched BMCs induces proliferation of the retinal neural cells.
Next, we examined whether the increased retinal neural cells were derived from injected BMCs or from host-derived retinal cells due to de novo proliferation under the stimulation of injected BMCs. The grafted cells, which expressed green fluorescence, were distributed around the injured sites (Figs. 1C and D) where the layers of the retina had been disordered. The patterns of distribution of the grafted cells were similar in all five experiments. Grafted cells were observed not only at the site of injury, where the normal retinal structure had been destroyed, but also in the surrounding area, where the normal retinal structure had been retained. Most of the grafted cells were located in the ONL, but some were in the inner nuclear layer (INL). When sections were stained with HE, the grafted cells were seen to be morphologically similar to the cells in the ONL. These results suggest that the injected stem cell-enriched BMCs had migrated into the retina, followed by proliferation and differentiation into retinal neural cells (Figs. 1B and D) .
Immunohistochemistry on Sections after Transplantation
To clarify that stem cell-enriched BMCs inoculated into the eyes have the ability to differentiate into nerve cells in the eye, immunohistochemical studies using confocal microscopy were performed 2 weeks after transplantation. The cell-type markers used were GFAP for astrocytes and Müller cells, calbindin for horizontal and amacrine cells, vimentin for glial cells, rhodopsin for rod photoreceptor cells, and CD45 for hematopoietic cells. The injected cells, which had been labeled with PKH-67, expressed green fluorescence, while the expressions of GFAP, carbindin, vimentin, and rhodopsin, which were labeled with R-PElabeled second Abs, were detected as red fluorescence. Therefore, the incorporated bone marrow-derived cells that expressed GFAP, carbindin, vimentin, or rhodopsin expressed yellow fluorescence. As shown in Figure 2 , some of the injected cells expressed GFAP, carbindin, vimentin, or rhodopsin (arrows), while some expressed green fluorescence, suggesting that some of the incorporated bone marrow cells had differentiated into retinal cells. We also examined the 
50, HE staining). (B) Cells in the ONL proliferated when stem cellenriched BMCs were injected (arrows) (original magnification × 50, HE staining). (C) The distribution of injected stem cell-enriched BMCs in the injured retina is observed as the cells showing green fluorescence (arrows), using confocal microscopy (original magnification × 20). (D) A continuous section of (C) was prepared, followed by staining with HE (original magnification × 25), and the figure shows the same place as (C). Proliferated cells in the ONL correspond to green fluorescence in (C) (arrows).
Representative data from five independent experiments are shown. expression of CD45 to detect hematopoietic cells. We detected CD45
+ cells in the retina injected with stem cellenriched BMCs, but CD45 -cells were more dominant than CD45 + cells in the retina (data not shown), and stem cell-enriched BMCs did not express GFAP, carbindin, vimentin, or rhodopsin (data not shown). These results strongly suggest that the injected stem cellenriched BMCs differentiated into the retinal neural cells.
DISCUSSION
It has been reported that BMCs differentiate into neural cells and astrocytes in cell culture [6, 7] . In this report, we have shown that stem cell-enriched BMCs injected into injured eyes can differentiate into retinal neural cells in vivo.
There have been several transplantation studies examining the differentiation of BMCs into neural retinal cells. Radner et al. subretinally transplanted the neural retinal tissue of newborn normal mice into C3H/HeJ (rd/rd) mice. The transplanted cells were incorporated into the retina and resided between the INL and the retinal pigment epithelium [16] . When brain-derived cell lines were transplanted into the retina, the cells were integrated into all major retinal cell layers [17] . Putative progenitors of retinal cells contained in the embryonic retina survived and differentiated into retinal cells in the transplanted eyes [18] . Embryonal retinas transplanted into the subretinal space survived in the host eyes [19] [20] [21] . In the above reports, retinal tissue was transplanted, and it is, therefore, difficult to apply these techniques to autotransplantation in clinical treatment. It has also been shown that hippocampus-derived neural stem cells, which have the capacity to differentiate into neural cells, astrocytes, and oligodendrocytes, migrate into the injured retina and differentiate into neural cells [22] [23] [24] [25] ; the incorporated cells express Map2ab, Map5 (the marker for mature neural cells), and GFAP, but not specific retinal cell markers (calbindin or rhodopsin) [22, 23] . In the present study, transplanted BMCs expressed not only GFAP and vimentin but also calbindin and rhodopsin, which are considered to be retinal cell-specific markers. It has been described that BMCs include pluripotent stem cells, which can differentiate into not only hematopoietic cells but also epithelial cells, endothelial cells, and nerve cells in the various organs. Therefore, our results suggest that BMCs contain more primitive stem cells than hippocampus-derived neural stem cells, and that the injection of BMCs into the eye can potentially rescue injured retinal tissue, even in humans.
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